Peptide synthesis platform allows high throughput synthesis of custom peptide libraries (6-20 amino acids) comprising thousands of peptides at 70% purity
Sigma-Genosys, a division of Sigma-Aldrich, has developed a new proprietary high throughput custom peptide synthesis platform using state-of-the-art technology.
The Pepscreen peptide synthesis platform allows high throughput synthesis of custom peptide libraries (6-20 amino acids) comprising thousands of peptides at 70% purity.
Higher purity is available upon request. Peptides are synthesised in quantities from 0.5-2mg in which 100% of the peptides are analysed by Maldi-Tof mass spectroscopy.
The unprecedented speed and efficiency of the Pepscreen synthesis platform allows peptide libraries to be synthesised analysed and delivered in less than seven days, says Sigma.
Pepscreen provides a novel solution that enables peptide-screening applications that were previously cost prohibitive.
These peptide libraries can be used in a large diversity of applications such as epitope mapping, interaction profiling, substrate specificity profiling, vaccine development, immunogen detection, peptide microarray production, protein-protein (or receptor-ligand) interactions and alanine scans.
"Until now, the cost, complexity and delivery time of custom peptide synthesis has made peptide screening applications beyond the affordability of the research community. "Sigma-Genosys's novel and innovative Pepscreen technology will enable large numbers of researchers in all industry sectors to rapidly screen hundreds to thousands of peptides in a variety of functional assays at a dramatically reduced cost," says Michael Hadjisavas, global strategic marketing manager for protein expression and proteomics.
